These are cells involved in the control of peripheral immunity, preventing autoreactive lymphocytes from being activated. They prevent immune reactions from being triggered when there is no infection or tumour cells.
There are two types of regulatory T cells:
- Intrinsic or natural (nTreg): generated in the thymus itself. These cells express CD4+ on their membrane (they are helper cells). In many cases they also express CD25+ (they are activated cells) and Foxp3+ (involved in the signal transcription pathway). These cells leave the thymus and exert their function in two ways.
- Antigen-inducible (iTreg): they acquire their regulatory capacity in the periphery. They acquire this capacity depending on the circumstances of the environment; they are not always regulatory. They do not differ greatly in the expression of membrane markers: CD4+, and sometimes (less frequently) CD25+ and Foxp3+. It depends on the APC, for example dendritic cells. That is, if the appropriate cytokines are present (IL10 and TGF-β), they are transformed into Treg cells. When APCs produce IL10 or TGF-β (in the absence of antigens or stress signals, which is what should happen in healthy individuals), these regulatory cells are produced. Two subtypes:
- Tr1: they produce IL10.
- Th3: they produce TGF-β.
These are cytokines with a clear inhibitory effect
These two cytokines are produced by dendritic cells to generate regulatory T cells, which in turn produce the same cytokines (a positive feedback loop to maintain the activation of this type of cell). This circle is broken when a pathogen enters and the dendritic cells are activated. They then stop producing IL10 and/or TGF-β and begin to synthesise IL-12, and the various immune reactions are set in motion.

Not all regulatory T cells are CD4 positive. There is a population of regulatory T cells that are CD8+. They do not act through the production of cytokines but often by direct contact: induction of apoptosis of effector cells. But the effect is still the same: regulation by elimination of effector cells (they reduce the activation, proliferation and clone formation of these effector cells).
The origin of Tregs is not clear; they are thought to recognise self antigens with a certain affinity, but the precise mechanism is not known.
When cells leaving the thymus recognise self antigens, they can:
- Activate Tregs and induce apoptosis, which is the most effective mechanism because it destroys the cell but does not cause inflammation.
- Recognise self antigens on a cell that is not a professional APC (it does not express MHC class II or costimulatory molecules), and cause the cell to become anergic (functional inactivation). But it remains in the body and is not eliminated, because it has a function: it cleans up and sticks to the TCR any antigen that has been left behind, preventing it from binding to other cells.

Intrinsic regulatory cells are activated and exert their function by direct contact, cell to cell. They inhibit Ag presentation and reduce the proliferation of effector cells. Some of the natural regulatory T cells that leave the thymus may be CD25- and therefore not activated (they recognise self antigens with low affinity) but they do exert their function as regulatory T cells. However, all the antigen-inducible ones that are activated locally in tissues usually express CD25, and not all express FOXP3.
Th3, Tr1 and induced cells are mostly CD4+ and produce cytokines (IL-10, TGF-β). Their effects are:
- Reducing the membrane expression of MHC class II molecules.
- Reduction of costimulatory molecules to reduce the functional capacity of APCs and with it the activation of an immune response (they reduce antigen-presenting capacity).
- They also reduce the capacity to synthesise inflammatory cytokines (IL12).
All of them act on Th1, Th2 and CD8+ cells, preventing their proliferation.
Action of IL-10 and TGFβ (*what they act on is important):
- IL10: acts on antigen-presenting cells. For example, it prevents the APC from expressing all the molecules on its membrane, so it ceases to be a good APC. It also blocks IL-12 expression by the antigen-presenting cell, preventing the activation of functional cells, Th1, Th2 and cytolytic lymphocytes, owing to the absence of IL-12.
- TGFβ: always acts on T lymphocytes. It has an inhibitory effect on T cells.
Mechanisms of regulation by CD4+ regulatory T cells:
The mechanisms of action of Treg cells are mediated by direct cell contact or by cytokines.
- By cell contact:
- Direct inhibition of the cell (apoptosis or anergy).
- Treg cells act on APCs, which inhibit the effector cells.
- Through cytokines (TGFβ and IL10).
- They inhibit the effector cell.
- They inhibit Ag presentation by the APC.
Treg cells act on: CD4+ T cells, CD8+ T cells, monocytes, B cells acting as APCs and dendritic cells.

Types of CD4+ T cells
- CD4+CD25+: regulation by destruction of effector cells: APCs and other lymphocytes (by direct contact).
- CD4+CD25-: cells that produce cytokines (no direct contact). Important in the mechanisms of suppression of autoimmunity.
- Tr1 cells: IL10. Indirect suppression of T cells by acting on APCs.
- Th3 cells: TGFβ.

Above all, the last two are involved in the suppression of autoimmune phenomena.
CD8+ regulatory T cells
- NKT: they lie halfway between NK cells and T cells. They are major producers of cytokines and also act by cytolysis. As with all NK cells, they act in response to tumours.
- CD8+ CD28+: they leave the thymus as CD8+. In the periphery they acquire CD28. They induce the expression of HLA-E, which favours interactions leading to apoptosis.
- CD8+ CD28-: they induce the formation of inhibitory KIR and behave like NK cells.
They make up a very small population (1–2%). In some conditions these populations increase.

NKT cells: another lineage of effector lymphocytes
They are so called because they are intermediate between NK and T cells. They carry NK markers and express a TCR with an invariant TCRα chain. They behave like NK cells, but have a TCR that recognises lipid antigens (membrane glycolipids) presented by CD1d molecules (the third pathway of antigen presentation). They develop in the thymus and are cells of adaptive immunity, but with shortcomings, since they do not form memory cells.
Depending on their degree of stimulation they carry out different functions, all of them involved in cellular responses against intracellular pathogens.
- They have direct cytolytic capacity.
- They induce the activation of Th1 cells and of effector CD8+ cells through the production of Ninfo.
- They activate NK cells and macrophages through the release of IFNγ.
- They regulate anti-infective and anti-tumour immune responses: stress cells. For example, Fas and Fas-L induce apoptosis. NKT cells can induce apoptosis in cells that have Fas on their membrane. In the intestine they could be responsible for destroying cells of the intestinal epithelium in order to repair them.
- NKT cells provide a bridge between innate and adaptive immunity.
